1-4 of 4
Authors: Xieqiao Yan
Save search
Sort by
Journal Article

Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinoma

PDF
Bixia Tang and others
The Oncologist, Volume 30, Issue 2, February 2025, oyae260, https://doi.org/10.1093/oncolo/oyae260
Published: 17 October 2024
Journal Article

Predominance of hyperprogression in mucosal melanoma during anti-PD-1 monotherapy treatment

PDF
Li Zhou and others
The Oncologist, Volume 30, Issue 2, February 2025, oyae211, https://doi.org/10.1093/oncolo/oyae211
Published: 20 August 2024
Journal Article

Five-Year Follow-Up of POLARIS-01 Phase II Trial: Toripalimab as Salvage Monotherapy in Chinese Patients With Advanced Melanoma

PDF
Bixia Tang and others
The Oncologist, Volume 29, Issue 6, June 2024, Pages e822–e827, https://doi.org/10.1093/oncolo/oyae045
Published: 28 March 2024
Journal Article

HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population

PDF
Li Zhou and others
The Oncologist, Volume 28, Issue 8, August 2023, Pages e617–e624, https://doi.org/10.1093/oncolo/oyad070
Published: 27 March 2023